Your browser doesn't support javascript.
loading
Resolution of Pain after Percutaneous Image-Guided Cryoablation of Extraperitoneal Endometriosis.
Najdawi, Milan; Razakamanantsoa, Leo; Mousseaux, Cyril; Bendifallah, Sofiane; Touboul, Cyril; Thomassin-Naggara, Isabelle; Bazot, Marc; Barral, Matthias; Cornelis, Francois H.
Afiliação
  • Najdawi M; Department of Interventional Radiology and Oncology, Tenon Hospital, Sorbonne University, Paris, France.
  • Razakamanantsoa L; Department of Interventional Radiology and Oncology, Tenon Hospital, Sorbonne University, Paris, France.
  • Mousseaux C; Department of Nephrology, Tenon Hospital, Sorbonne University, Paris, France.
  • Bendifallah S; Department of Gynecology, Tenon Hospital, Sorbonne University, Paris, France.
  • Touboul C; Department of Gynecology, Tenon Hospital, Sorbonne University, Paris, France.
  • Thomassin-Naggara I; Department of Interventional Radiology and Oncology, Tenon Hospital, Sorbonne University, Paris, France.
  • Bazot M; Department of Interventional Radiology and Oncology, Tenon Hospital, Sorbonne University, Paris, France.
  • Barral M; Department of Interventional Radiology and Oncology, Tenon Hospital, Sorbonne University, Paris, France.
  • Cornelis FH; Department of Interventional Radiology and Oncology, Tenon Hospital, Sorbonne University, Paris, France; Interventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: cornelisfrancois@gmail.com.
J Vasc Interv Radiol ; 34(7): 1192-1198, 2023 07.
Article em En | MEDLINE | ID: mdl-37003579
PURPOSE: To retrospectively evaluate the relief of pain after percutaneous image-guided cryoablation of symptomatic extraperitoneal endometriosis (EE). MATERIAL AND METHODS: From 2017 to 2022, cryoablation of EE was performed at a single institution on a total of 47 lesions in 42 consecutive patients (median age, 37 years; interquartile range [IQR], 33-39.5 years). Patient and procedural characteristics were reviewed retrospectively. Tolerance and outcomes in terms of pain and patient satisfaction were evaluated. RESULTS: The median follow-up duration was 13.5 months (IQR, 1.1-37.7 months) after cryoablation. The median pain-free survival rate was 93.8% (95% confidence interval [CI], 77.3-98.4) at 6 months and 82.7% (95% CI, 58.8-93.5) after 12 months. Pain decreased from a median of 8/10 (IQR, 7-9) on the visual analog scale to 0/10 (IQR, 0-1) at the last follow-up (P < .0001). The median Patient Global Impression of Change score recorded at the last follow-up was 1/7 (IQR, 1-2). The efficacy rate of cryoablation to avoid secondary surgery was 92.8% (39/42) per patient and 93.6% (44/47) per nodule treated. Four patients (9.5%, 4/42) experienced an adverse event in the days following the procedure, and 1 patient (2%) experienced a severe adverse event. CONCLUSIONS: Percutaneous cryoablation is safe and effective in significantly reducing pain and obtaining local control of EE.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Criocirurgia / Endometriose Tipo de estudo: Etiology_studies / Observational_studies Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Criocirurgia / Endometriose Tipo de estudo: Etiology_studies / Observational_studies Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article